FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/07/071730 [Registered on: 31/07/2024] Trial Registered Prospectively
Last Modified On: 29/05/2026
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Physiotherapy (Not Including YOGA) 
Study Design  Other 
Public Title of Study   A clinical trial to study the effects of community-based pulmonary rehabilitation (PR) program in improving quality of life of patients with silicosis 
Scientific Title of Study   Effectiveness of an 8-week community-based pulmonary rehabilitation (PR) program in improving the health-related quality of life among patients with silicosis  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
IIRP-2023-0000219  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Rakshit Shah 
Designation  Scientist B 
Affiliation  ICMR - National Institute of Occupational Health 
Address  3rd floor, Health Sciences Division, ICMR - National Institute of Occupational Health, Near Raksha Shakti University, Meghaninagar, Ahmedabad, Gujarat

Ahmadabad
GUJARAT
380016
India 
Phone  9429113289  
Fax    
Email  rakshit.shah@icmr.gov.in  
 
Details of Contact Person
Scientific Query
 
Name  Dr Rakshit Shah 
Designation  Scientist B 
Affiliation  ICMR - National Institute of Occupational Health 
Address  3rd floor, Health Sciences Division, ICMR - National Institute of Occupational Health, Near Raksha Shakti University, Meghaninagar, Ahmedabad, Gujarat

Ahmadabad
GUJARAT
380016
India 
Phone  9429113289  
Fax    
Email  rakshit.shah@icmr.gov.in  
 
Details of Contact Person
Public Query
 
Name  Dr Rakshit Shah 
Designation  Scientist B 
Affiliation  ICMR - National Institute of Occupational Health 
Address  3rd floor, Health Sciences Division, ICMR - National Institute of Occupational Health, Near Raksha Shakti University, Meghaninagar, Ahmedabad, Gujarat

Ahmadabad
GUJARAT
380016
India 
Phone  9429113289  
Fax    
Email  rakshit.shah@icmr.gov.in  
 
Source of Monetary or Material Support  
Indian Council of Medical Research, V. Ramalingaswami Bhawan, P.O. Box No. 4911 Ansari Nagar, New Delhi - 110029, India Email: icmrhqds[at]sansad[dot]nic[dot]in 
 
Primary Sponsor  
Name  Indian Council of Medical Research 
Address  V. Ramalingaswami Bhawan, P.O. Box No. 4911, Ansari Nagar, New Delhi - 110029, India 
Type of Sponsor  Government funding agency 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Rakshit Shah  Pindwara,Swaroopganj  Pindwara Community Health Center (CHC), Pindwara, Sirohi, SH-62, Sirohi Road, Sirohi District, Rajasthan 307022 AND Swaroopganj Community Health Centre (CHC), Swaroopganj, Sirohi District, Rajasthan, 307023.
Sirohi
RAJASTHAN 
9429113289

rakshit.shah@icmr.gov.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
ICMR-National Institute of Occupational Health Human Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: J841||Other interstitial pulmonary diseases with fibrosis,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  8 week Community-based Pulmonary Rehabilitation program  A community-based pulmonary rehabilitation (PR) program will be conducted for the silicosis patients recruited at CHC Pindwara (the intervention site), twice-a-week for a total duration of 8 weeks. The community-based PR program will include basic, low-intensity exercises that can be delivered without the use of costly equipment such as treadmills/ cycle ergometers/ dumb-bels, etc. The specific exercises will include low-intensity exercises focusing on breathing, inspiratory muscle training, 6 minute walking, and freehand limb exercises.  
Comparator Agent  NIL  No active intervention 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  99.00 Year(s)
Gender  Both 
Details  We would include adult patients, equal to or more than 18 years age having a definitive diagnosis of silicosis, made by the Pneumoconiosis Board of the Rajasthan government, and residing in the geographic limits of the Pindwara block of Sirohi district of Rajasthan as the study participants. 
 
ExclusionCriteria 
Details  We would exclude the silicosis patients that meet any of the following criteria: 1) those who are not willing to participate (in the assessments/ study intervention), 2) requiring supplemental oxygen therapy, 3) unable to complete the 6-minute walk distance test (patient stops and refuses to continue/ test stopped due to the patient having complaint of chest pain/ intolerable dyspnea), 4) having history of syncope on exertion, 5) history of CVS conditions such as myocardial infarction/ stroke, 6) history of any pulmonary infections such as pneumonia, or tuberculosis in the last 6 weeks, 7) concomitant presence of other lung conditions such as bronchial asthma, pneumothorax, sarcoidosis, bronchiectasis and hypersensitivity pneumonitis, and 8) those unable to follow the commands provided by the investigators/ research team members providing intervention. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
The primary outcome variable will be the health-related quality of life - HRQoL, which would be assessed using the mean or median differences in the pre-post scores of the St. George Research Questionnaire (Total, Symptoms, Activity, and Impact scores), in the intervention and the comparison groups. This would be a continuous variable. The St. George Research Questionnaire (SGRQ) is a standardized tool to assess health-related quality of life and has been validated for use in various chronic respiratory disorders, including restrictive lung diseases such as idiopathic pulmonary fibrosis  Will be assessed at baseline and at 8 weeks, i.e. after the completion of the study intervention in the intervention group and after 8 weeks of the baseline assessment in the control group 
 
Secondary Outcome  
Outcome  TimePoints 
Six minute walk distance time  8 weeks from baseline 
Modified Medical Research Council scale grading  8 weeks from baseline 
Borg Rating of perceived exertion scale scores  8 weeks from baseline 
% Predicted FVC, % Predicted FEV1  8 weeks from baseline 
 
Target Sample Size   Total Sample Size="250"
Sample Size from India="250" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/11/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Informed Consent Form
    Response - Clinical Study Report
    Response -  Analytic Code

  3. Who will be able to view these files?
    Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.

  4. For what types of analyses will this data be available?
    Response - For individual participant data meta-analysis.

  5. By what mechanism will data be made available?
    Response (Others) -  Data will be available from the corresponding author upon a reasonable request

  6. For how long will this data be available start date provided 01-11-2026 and end date provided 01-11-2096?
    Response - Immediately following publication. No end date.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary  
Rationale: Silicosis has no cure, and the focus is on improving the health-related quality of life (HRQoL) for affected individuals. Hospital-based pulmonary rehabilitation (PR) programs have shown effectiveness in enhancing the HRQoL for occupational lung disease (asbestosis/silicosis) patients. However, most patients are from the lower socio-economic status and reside in rural areas with limited access to tertiary healthcare facilities. Currently, evidence is lacking in relation to the effectiveness of less physically intensive, community-based PR programs for improving HRQoL of silicosis patients
Novelty: This study will generate new evidence, on whether community-based PR programs (which include only basic, low-intensity exercises) are effective in improving the HRQoL of silicosis patients. We wish to determine the effectiveness of the PR program so as to be taken up by health and wellness centers (HWCs) later on.
Objective: To determine the effectiveness of an 8-week community-based pulmonary rehabilitation program, on improvement in the health-related quality of life of patients with silicosis.
Methods: This quasi-experimental interventional study will enroll 170 silicosis patients, with CHC Pindwara designated as the intervention center and CHC Swaroopganj as the comparison center. Participants in the intervention group will undergo the 8-week PR program, which includes low-intensity exercises focusing on breathing, inspiratory muscle training, walking, and freehand limb exercises. Baseline and post-intervention assessments will be conducted to measure changes in HRQoL, aerobic capacity, perceived dyspnea, and pulmonary function.
Expected Outcomes: It is expected that the community-based PR program will significantly improve the HRQoL of silicosis patients.
 
Close